PO Box 58871
London SE15 9BE, UK
+44 (0)7794 485294

Cedilla Publishing highly commended at 2016 BMA Medical Book Awards
We are delighted to announce that our GP pain handbook, The 10-minute consultation: persistent pain, was highly commended in the primary health care category at the 2016 BMA Medical Book Awards.

The GP judging panel commented:
"Pain management is an increasingly challenging field in general practice and this [guide] brings together a lot of useful information. It is comprehensive while concise and includes a good range from the best scientific evidence through to holistic approaches. I checked some of the sections and found them to be both accurate and up-to-date. It is a good introduction to the subject."

If you are interested in purchasing copies or translation rights, please contact Sarah Findlay on +44 (0)7794 485294 or email info@cedillapublishing.com.

News Archive

Children in England 'deserve better' from healthcare
Tue, 23 Jan 2018 09:40:46 GMT
England has not made the same strides as Wales and Scotland to improve care, a report says.
The good A&E facing unprecedented winter pressures
Tue, 23 Jan 2018 08:34:10 GMT
How a hospital with some of the best NHS waiting times ended up with patients waiting in corridors.
Asthma patients 'not receiving basic care'
Tue, 23 Jan 2018 00:10:52 GMT
Majority of patients do not get the basic care which could prevent two out of three asthma deaths
Teva?s subcutaneous asthma drug fails in PhIII
Tue, 23 Jan 2018 11:33:05 +0000
Teva’s quest to expand approval of its respiratory drug Cinquair/Cinqaero with a new mode of delivery has hit a snag, after two late-stage studies failed to hit their targets.
Rexgenero wins 1.4m grant from Innovate UK
Tue, 23 Jan 2018 10:58:09 +0000
London, UK-based Rexgenero has secured with partners 1.4 million in funding for a 1.8 million project from the UK’s innovation agency Innovate UK, for an industrial research project on the commercial manufacture of its product REX-001.
Astellas bags orphan drug status for AML drug
Tue, 23 Jan 2018 10:46:24 +0000
Astellas’ experimental acute myeloid leukaemia drug gilteritinib has been awarded orphan drug designation by the European Commission.
Practices 'give up' on recruiting GPs as one in three face long-term vacancies
Mon, 22 Jan 2018 15:28:24 Z
Many practices have 'given up' trying to fill GP vacancies, the BMA's GP committee chair has warned, as a poll suggested that thousands of posts across England are vacant.
Welsh LMCs hit out at health boards ignoring GP contract
Mon, 22 Jan 2018 16:47:29 Z
GP leaders in Wales have hit out at health boards diverting GMS funding away from practices and ignoring parts of the GP contract, with the BMA warning it could press for a single body to administer primary care across the country.
Solve Capita problems now to keep patients safe, BMA warns Simon Stevens
Mon, 22 Jan 2018 10:15:19 Z
Patients are being put at risk because 'shambolic' primary care support services run by outsourcing firm Capita have seen practices sent incorrect patient records and care requests delayed, the BMA has told NHS England.


Cedilla Publishing Limited, PO Box 58871, London SE15 9BE, United Kingdom. Tel: +44 (0)7794 485294. Email: info@cedillapublishing.com
All site content ©2006-2018 Cedilla Publishing Limited. All rights reserved. Cookies & Privacy.